Fallopian Cancer
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations (NCT07038369) | Atavistik Bio, Inc | 2025-07-29 |
| Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer (NCT01580696) | COL George Peoples, MD, FACS | 2012-04-01 |
| Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer (NCT01104675) | CASI pharmaceuticals, Inc. | 2010-04-01 |
Track Fallopian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.